Intradialytic Profiling Strategies

Introduction to Intradialytic Profiling

• The American Society of Nephrology recommends against routine use of intradialytic profiling for most dialysis patients due to minimal benefit and potential harm, as shown in high-quality studies 1, 2

Blood Volume Monitoring

• The National Kidney Foundation notes that intradialytic blood volume monitoring is associated with higher mortality and hospitalization rates compared to conventional clinical monitoring, making routine use inadvisable 1, 2
• Blood volume monitoring has conflicting evidence regarding prediction of intradialytic hypotension, though it may have prognostic value in select cases 1, 2

Sodium Profiling

• The American Heart Association indicates that routine sodium profiling to prevent intradialytic hypotension is associated with increased all-cause mortality, making it unsuitable for routine use 1, 2
• The European Renal Association suggests that sodium profiling must be used judiciously as it results in sodium loading, hypervolemia, increased thirst, and greater interdialytic weight gain 1, 2, 3

Temperature Biofeedback

• The International Society of Nephrology recommends cooling dialysate temperature to 0.5°C below body temperature for hemodynamic stability 1, 2
• Isothermic hemodialysis reduced intradialytic morbid events by 25% compared to standard approaches in hypotension-prone patients 3

Ultrafiltration Profiling

• The American Society of Nephrology states that randomized controlled trial data on ultrafiltration profiling independent of blood volume monitoring and sodium profiling are scarce 1, 2

Dialysate Calcium

• The National Kidney Foundation notes that dialysate calcium of 2.5 mEq/L is associated with decreased left ventricular contractility and significant intradialytic hypotension in cardiac-compromised patients 3

Alternative Approaches

• The European Renal Association suggests that hemodiafiltration demonstrates significant reduction in intradialytic hypotension compared to regular hemodialysis, with better hemodynamic stability at higher convection volumes 1, 2
• Midodrine improves intradialytic and postdialytic blood pressures by maintaining central blood volume and cardiac output 3

Clinical Examination

• The International Society of Nephrology recommends clinical examination as the primary method for volume assessment in resource-constrained environments 1, 2
• Signs and symptoms of volume status include breathlessness, orthopnea, edema, elevated jugular venous pressure, cardiomegaly, lung congestion, light-headedness, cramps, and weight changes 1, 2

Common Pitfalls to Avoid

• The American Society of Nephrology advises against implementing routine blood volume monitoring based on older literature, as the CLIMB trial showed harm 1, 2
• The American Heart Association recommends avoiding routine sodium profiling given the DOPPS mortality data, reserving it for highly selected cases only 1, 2

Sodium Management in Dialysis Patients

Guideline Recommendations

• The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines explicitly state that increasing positive sodium balance by "sodium profiling" or using high dialysate sodium concentration should be avoided (Grade B recommendation) 4, 5

Adverse Physiological Effects

• Interdialytic weight gain exceeding 4.8% of body weight is associated with increased mortality when adjusted for comorbidity 4, 5

Volume Expansion Mechanism

• The osmotic gradient generated by dietary sodium addition to the extracellular fluid compartment causes water to move from cells into the extracellular space, expanding extracellular fluid volume 4, 5
• The increase in extracellular fluid osmolality stimulates the hypothalamus thirst center, increasing water intake and creating a vicious cycle 4, 5

Cardiovascular Consequences

• Poor volume control from positive sodium balance exacerbates hypertension and its detrimental effects on the cardiovascular system 4, 5
• Volume and blood pressure are inextricably linked in dialysis patients, making sodium management critical for cardiovascular outcomes 4, 5

Volume Control Strategy

• Optimize ultrafiltration with the goal of rendering patients euvolemic and normotensive through adequate ultrafiltration and achieving true dry weight 4, 5
• Counsel patients on sodium restriction to no more than 5 g of sodium chloride (2.0 g or 85 mmol of sodium) daily 4, 5
• Use diuretics in patients with residual kidney function to assist with volume management 4, 5